What Is Gentamicin Ototoxicity?

Gentamicin is an aminoglycoside antibiotic used to treat serious bacterial infections. Like other medications in this class, it can damage the inner ear. This is called ototoxicity. Gentamicin ototoxicity may affect the vestibular system, the hearing system, or both. Because gentamicin is often given in hospital settings for severe infections, the balance effects may be overlooked while a person is unwell or lying in bed.

The vestibular effects are particularly important. Gentamicin can injure the hair cells of the vestibular organs on both sides of the inner ear. This can produce a bilateral vestibular weakness, sometimes described as a bilateral vestibulopathy. The hearing effects can also be bilateral, and hearing loss may be permanent.

Vestibular Toxicity and Vestibulopathy

Vestibular toxicity from gentamicin can damage the balance sensors that detect head movement and position. When both sides are affected, the brain receives reduced or distorted information about motion. This is a form of vestibulopathy. A person may notice dizziness, a sense of rotation, or a rotatory vertigo that is worse with movement. However, profound bilateral vestibular loss may not cause classic spinning vertigo after the acute phase; instead, it often causes persistent imbalance and unsteadiness.

Because the damage is bilateral, the brain cannot rely on one healthy ear to compensate. This can make recovery slower and more incomplete. People may feel unsteady when walking in the dark, on uneven ground, or when turning the head. Some describe a floating or rocking sensation rather than true rotatory dizziness.

Common Symptoms

• Dizziness, lightheadedness, or a sense of motion
• Rotatory vertigo, especially during the early or acute phase
• Imbalance and unsteadiness while standing or walking
• Ataxia, with a wide-based or uncoordinated gait
• Oscillopsia, in which the visual world appears to bounce or blur with head movement
• Hearing loss, tinnitus, or a feeling of fullness in the ears
• Nausea or discomfort with movement

Oscillopsia is especially suggestive of bilateral vestibular loss. It occurs because the eyes cannot stabilize the visual image during head movement. A person may report that reading or recognizing faces is difficult while walking. Unsteadiness and ataxia may be more prominent than spinning dizziness, particularly after the initial period.

Hearing Effects

Gentamicin can also damage the cochlea, the hearing organ of the inner ear. Hearing loss may begin at high frequencies and can progress. It may be bilateral and may be irreversible. Some people develop tinnitus or difficulty understanding speech in background noise. Hearing changes can occur alongside vestibular symptoms, but either problem may appear alone. Regular hearing testing may help identify changes when gentamicin is used for a prolonged period or when other risk factors are present.

Risk Factors and Monitoring

The risk of gentamicin ototoxicity depends on several factors. These include the dose and duration of treatment, kidney function, age, dehydration, and exposure to other medications that can harm the ear or kidney. A history of hearing loss or balance disorder may also increase concern. Genetic factors can influence susceptibility in some people, but they do not explain every case.

Monitoring may include questions about dizziness, imbalance, oscillopsia, unsteadiness, ataxia, and hearing changes. Hearing tests and vestibular testing can help characterize the problem. When gentamicin is medically necessary, clinicians may adjust the dose, check kidney function, and monitor drug levels. Any new balance or hearing symptom during or after treatment should be reported promptly.

Assessment and Management

Evaluation usually begins with a careful history of medication exposure, symptom timing, and functional difficulties. Examination may look for nystagmus, gait ataxia, and impaired balance. Hearing evaluation and vestibular function testing can help confirm the pattern and severity of involvement. Because gentamicin-related vestibular damage is often bilateral, testing may show reduced responses on both sides.

There is no simple treatment that reverses gentamicin ototoxicity. Management focuses on preventing further exposure when possible, treating the underlying infection, and supporting balance and hearing. Vestibular rehabilitation can help some people adapt to chronic imbalance and unsteadiness. Hearing aids or other hearing support may be useful when hearing loss is permanent. People with severe bilateral vestibulopathy need to take particular care to reduce fall risk and to use good lighting and stable supports when walking.

When to Seek Help

New dizziness, rotatory vertigo, oscillopsia, imbalance, unsteadiness, ataxia, or hearing change after gentamicin should be evaluated by a healthcare professional. Urgent assessment is important if symptoms are severe, sudden, or accompanied by weakness, numbness, speech difficulty, vision loss, or other neurological signs. Earlier recognition can help guide medication decisions and supportive care.